When is crossover desirable in cancer drug trials and when is it problematic?

A. Haslam, V. Prasad

Research output: Contribution to journalEditorial

2 Scopus citations
Original languageEnglish
Number of pages1
JournalAnnals of Oncology
Volume29
Issue number5
DOIs
Publication statusPublished - 1 May 2018
Externally publishedYes

Cite this